Lavipharm S.A.'s total assets for Q2 2026 were €140.09M, an increase of 7.20% from the previous quarter. DE:BXA0 total liabilities were €83.73M for the fiscal quarter, a 12.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.